DR. Mark Andrew Rouff, M.D. is a pain medicine pain medicine in Yuma, AZ with 10 years of experience. The provider is pain Medicine is a primary medical specialty based on a distinct body of knowledge and a well-defined scope of clinical practice that is founded on science, research and education. It is concerned with the study of pain, the prevention of pain, and the evaluation, treatment, and rehabilitation of persons in pain. A comprehensive evaluation incorporates the physical, psychological, cognitive and socio-cultural contributions to pain. The treatment protocol may include pharmacological, invasive, behavioral, cognitive, rehabilitative and complementary strategies provided in a concurrent focused and patient specific manner. The pain medicine physician often serves the patient as a frontline physician regarding their pain, but also may serve as a consultant to other physicians, direct an interdisciplinary/multidisciplinary treatment team, conduct research, or advocate for the patient's pain care with public and private agencies. The Pain Medicine physician may work in variety of settings including office, clinic, hospital, university, or governmental/public agencies. DR. Mark Andrew Rouff, M.D. NPI is 1609255512. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
The provider's business location address is:
2460 S PARKVIEW LOOP STE 3
YUMA, AZ
ZIP 85364-357
Phone: (928) 336-7846
Fax: (928) 336-1776
The NPI 1609255512 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
- Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
- Ultrasonic guidance imaging supervision and interpretation for insertion of needle (HCPCS:76942)
- Testing for presence of drug (HCPCS:80307)
- Aspiration and/or injection of large joint or joint capsule (HCPCS:20610)
- Injection of substance into spinal canal of lower back or sacrum using imaging guidance (HCPCS:62323)
The enumeration date for this NPI number is 5/26/2015 and was last updated on 7/27/2022.